Carenoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders like gastroesophageal reflux disease. This category contains a range of analytical tools essential… Read more
Carenoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders like gastroesophageal reflux disease. This category contains a range of analytical tools essential for pharmaceutical research, including the active pharmaceutical ingredient, potential drug impurities, and specialized metabolic products. Laboratories utilize these high-purity reference standards to perform rigorous impurity profiling, ensuring compliance with safety and quality regulations during drug development. The collection includes stable isotope labelled compounds, such as deuterium and 13C-labelled analogs, which serve as critical internal standards for accurate quantification in complex matrices using liquid chromatography-mass spectrometry (LC-MS) and other analytical techniques. By providing precise control materials for method validation and stability testing, these compounds support the investigation of degradation pathways, including the detection of potential mutagenic impurities like N-nitroso derivatives, facilitating robust quality control throughout the lifecycle of the drug.